In vitro production of progesterone and estradiol by rat granulosa cells regulated by cabergoline and prolactin

Endocrine Research

Volumn 24, Issue 2, 1998, Pages 195-203

  Negishi, H ^a   Furuta, I ^a   Ushigoe, K ^b   Fujimoto, S ^a   Koide, S S ^c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c POPULATION COUNCIL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CABERGOLINE; DIETHYLSTILBESTROL; ESTRADIOL; FOLLITROPIN; PENICILLIN G; PROGESTERONE; PROLACTIN; STREPTOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; FEMALE; GRANULOSA CELL; HORMONAL REGULATION; HORMONE INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; OVARY; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROGESTERONE SYNTHESIS; RAT; STEROIDOGENESIS;

EID: 0031782764     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809809135528     Document Type: Article

References (23)

1. Ferrari C, Paracchi A, Mattei AM, de Vincentis S, D'Alberton A, Crosignami PG. 1992 Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta Endocrinol 126:489-494.
2. Rains CP, Bryson HM, Fitton A. 1995 Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 49:255-279.
3. Andreotti A-C, Pianezzola E, Persiani S, Pacciarini MA, Strolin-Benedetti M, Pontirol AE. 1995 Pharmacokinetics, pharmacodynamics and tolerability of cabergoline, a prolactin lowering drug after administration of increasing oral doses (0.5, 1.0 and 1.5 milligrams) in healthy male volunteers. J Clin Endocrinol Metab 80:841-845.
4. 3H]N-n-propylnorapomorphine. Eur J Pharmacol 187:399-408.
5. Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, Kurisu K. 1995 Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: In vitro culture studies. Endocrine J 42:413-420.
6. Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, Kurisu K. 1995 In vitro effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors. Endocrine J 42:153-161.
7. Mori H, Arakawa S, Ohkawa T, Ohkawa R, Takada S, Morita T, Okinaga S. 1994 The involvement of dopamine in the regulation of steroidogenesis in rat ovarian cells. Hormone Res 41 (Suppl 1):36-40.
8. Hsueh AJW, Wang C, Erickson GF. 1980 Direct inhibitory effect of gonadotropin-releasing hormone upon follicle-stimulating hormone induction of luteinizing hormone receptor and aromatase activity in rat granulosa cells. Endocrinology 106:1697-1705.
9. Post K, Evans LE, Jöchle W. 1988 Effect of prolactin suppression with cabergoline in the pregnancy of the bitch. Theriogenolgy 29:1233-1243.
10. 2α, and a new anti-prolactinic agent, cabergoline. J Reprod Fert Suppl 47:411-417.
11. Rothchild I. 1981 The regulation of the mammalian corpus luteum. Recent Prog Horm Res 37:183-283.
12. Onclin K, Silva LDM, Donnay I, Verstegen JP. 1993 Luteotropic action of prolactin in dogs and the effect of a dopamine agonist, cabergoline. J Reprod Fert Suppl 47:403-409.
13. Willis D, Mason H, Gilling-Smith C, Frank S. 1996 Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302-309.
14. Christenson LK, Stouffer RL. 1997 Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 82:2135-2142.
15. Negishi H, Koide SS. 1997 Prevention and termination of pregnancy in the rat with cabergoline, a dopamine agonist. J Reprod Fertil 109:103-107.
16. Dorrington J, Gore-Langton RE. 1981 Prolactin inhibits oestrogen synthesis in the ovary. Nature 290:600-602.
17. Wang C, Chan V. 1982 Divergent effects of prolactin on estrogen and progesterone production by granulosa cells of rat Graafian follicles. Endocrinology 110:1085-1093.
18. Dorrington J, Gore-Langton RE. 1982 Antigonadal action of prolactin: further studies on the mechanism of inhibition of follicle-stimulating hormone-induced aromatase activity in rat granulosa cell cultures. Endocrinology 110:1701-1707.
19. Krasnow JS, Hickey GJ, Richard JS. 1990 Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol Endocrinol 4:13-21.
20. Bodis J, Tinneberg HR, Török A, Cledon P, Hanf V, Papenfuss F. 1993 Effect of noradrenaline and dopamine on progesterone and estradiol secretion of human granulosa cells. Acta Endocrinol 129:165-168.
21. Piomelli D, Pilon C, Ginos B, Sokoloff P, Matres MP, Schwartz JC. 1991 Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353:164-167.
22. Arakawa S, Yago N, Isobe S, Ohkawa R, Mori H, Okinaga S. 1994 Dopamine increases the ovarian progesterone synthesis of PMSG-treated rats by regulating 17β-hydroxy steroid dehydrogenase activity. Folia Endocrinol Japonica 70:447-456.
23. Ogawa N. 1995 Molecular and chemical neuropharmacology of dopamine receptor subtypes. Acta Med Okayama 49:1-11.